Aura Biosciences, Inc. (NASDAQ: AURA) was given a new $25.00 price target on by analysts at HC Wainwright.
Aura Biosciences, Inc. (NASDAQ: AURA) was given a new $19.00 price target on by analysts at JMP Securities.
Aura Biosciences, Inc. (NASDAQ: AURA) had its "outperform" rating re-affirmed by analysts at Citigroup Inc..
Aura Biosciences Announces Appointment of Teresa Bitetti to Board of Directors
Aura Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights